European Journal of Cancer
Volume 45, Issue 2 , Pages 268-274, January 2009

Lessons learned from independent central review

  • R. Ford

      Affiliations

    • RadPharm, 100 Overlook Center, Princeton, NJ 08540, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1 609 936 2604; fax: +1 609 514 4898.
    web address
  • ,
  • L. Schwartz

      Affiliations

    • Memorial Sloan Kettering Cancer Center, NY, USA
  • ,
  • J. Dancey

      Affiliations

    • National Cancer Institute of Canada – Clinical Trials Group, Kingston, ON, Canada
  • ,
  • L.E. Dodd

      Affiliations

    • National Cancer Institute, Bethesda, MD, USA
  • ,
  • E.A. Eisenhauer

      Affiliations

    • National Cancer Institute of Canada – Clinical Trials Group, Kingston, ON, Canada
  • ,
  • S. Gwyther

      Affiliations

    • East Surrey Hospital, Redhill, Surrey, UK
  • ,
  • L. Rubinstein

      Affiliations

    • National Cancer Institute, Bethesda, MD, USA
  • ,
  • D. Sargent

      Affiliations

    • Mayo Clinic, Rochester, MN, USA
  • ,
  • L. Shankar

      Affiliations

    • National Cancer Institute, Bethesda, MD, USA
  • ,
  • P. Therasse

      Affiliations

    • GlaxoSmithKline Biologicals, Rixensart, Belgium
  • ,
  • J. Verweij

      Affiliations

    • Erasmus University Medical Center, Rotterdam, The Netherlands

Received 17 October 2008; accepted 29 October 2008. published online 22 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(08)00879-4

doi:10.1016/j.ejca.2008.10.031

European Journal of Cancer
Volume 45, Issue 2 , Pages 268-274, January 2009